MedPath

APT PHARMA LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

152

PPB:152

Drug Approvals

AROZAC CAPSULES 10MG

Approval Date
Apr 24, 2025
PPB

SORBIMON PROLONGED-RELEASE TABLETS 60MG

Approval Date
Mar 28, 2025
PPB

APT-ISOSORBIDE DINITRATE TABLETS 10MG

Approval Date
Mar 27, 2025
PPB

APT-CIPROFLOXACIN TABLETS 250MG

Approval Date
Nov 29, 2024
PPB

EUROVILDA TABLETS 50MG

Approval Date
Feb 20, 2024
PPB

VILDAGUS TABLETS 50MG

Approval Date
Feb 1, 2024
PPB

APT-GEMFIBROZIL CAPSULES 300MG

Approval Date
Feb 1, 2024
PPB

APT-GEMFIBROZIL TABLETS 600MG

Approval Date
Nov 30, 2023
PPB

APT-DICLOFENAC EXTENDED-RELEASE TABLETS 100MG

Approval Date
Jan 12, 2023
PPB

APT-DIPYRIDAMOLE TABLETS 75MG

Approval Date
Feb 7, 2022
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.